au.\*:("ZILLIKEN F")
Results 1 to 19 of 19
Selection :
ANALYSIS OF LIPID COMPONENTS IN ORGANOTYPIC CULTURES OF CEREBELLUM DURING DEVELOPMENT.GIESING M; ZILLIKEN F.1976; BRAIN RES.; NETHERL.; DA. 1976; VOL. 111; NO 1; PP. 212-219; BIBL. 18 REF.Article
LIPID METABOLISM OF DEVELOPING CENTRAL NERVOUS TISSUES IN ORGANOTYPIC CULTURES. III: GANGLIONIC CONTROL OF GLYCEROLIPIDS AND FATTY ACIDS IN CORTEX GREY MATTERGIESING M; ZILLIKEN F.1980; NEUROCHEM. RES.; USA; DA. 1980; VOL. 5; NO 3; PP. 257-270; BIBL. 40 REF.Article
LIPID METABOLISM OF DEVELOPING CENTRAL NERVOUS TISSUES IN ORGANOTYPIC CULTURES. II. A COMPARATIVE STUDY OF MEDIUM AND TISSUE FATTY ACIDS IN DEVELOPING RAT CEREBRAL CORTEX AND CEREBELLUM.GIESING M; ZILLIKEN F.1975; NUTRIT. AND METABOL.; SWITZ.; DA. 1975; VOL. 19; NO 5-6; PP. 251-262; BIBL. 21 REF.Article
QUANTITATIVE BESTIMMUNG DUNNSCHICHTCHROMATOGRAPHISCH GETRENNTER LIPIDE AUS SERUM UND GEWEBE DURCH UV-ABSORPTIONSMESSUNG IN REMISSION = DOSAGE DES LIPIDES DU SERUM ET DES TISSUS ISOLES PAR CHROMATOGRAPHIE EN COUCHE MINCE, PAR ABSORPTION UV EN REMISSIONMURAWSKI U; EGGE H; ZILLIKEN F et al.1974; Z. KLIN. CHEM. KLIN. BIOCHEM.; DTSCH.; DA. 1974; VOL. 12; NO 10; PP. 464-467; ABS. ANGL.; BIBL. 5REF.Article
SUBSTRATE SPECIFICITY OF NEURAMINIDASE FROM ERYSIPELOTHRIX RHUSIOPATHIAE.VON NICOLAI H; MULLER HE; ZILLIKEN F et al.1978; Z. (HOPE-SEYLER'S) PHYSIOL. CHEM.; DTSCH.; DA. 1978; VOL. 359; NO 3; PP. 393-398; ABS. ALLEM.; BIBL. 28 REF.Article
MICHAELIS-KONSTANTEN VON NEURAMINIDASEN BEI PATHOGENEN UND APATHOGENEN MIKROORGANISMEN = LES CONSTANTES DE MICHAELIS DES NEURAMINIDASES DANS LES MICROORGANISMES PATHOGENES ET APATHOGENESMULLER HE; VON NICOLAI H; ZILLIKEN F et al.1975; Z. NATURFORSCH., C; DTSCH.; DA. 1975; VOL. 30; NO 3; PP. 417-419; ABS. ANGL.; BIBL. 23REF.Article
CARBON-13 CHEMICAL SHIFT ASSIGNMENTS OF CHROMONES AND ISOFLAVONESHEM CHANDRA JHA; ZILLIKEN F; BREITMAIER E et al.1980; CAN. J. CHEM.; ISSN 0008-4042; CAN; DA. 1980; VOL. 58; NO 12; PP. 1211-1219; ABS. FRE; BIBL. 21 REF.Article
PURIFICATION AND PROPERTIES OF TWO NEURAMINIDASES FROM STREPTOCOCCUS VIRIDANS IIVON NICOLAI H; MUELLER HE; ZILLIKEN F et al.1980; F.E.B.S. LETTERS; NLD; DA. 1980; VOL. 117; NO 1; PP. 107-110; BIBL. 19 REF.Article
PROPERTIES AND SUBSTRATE SPECIFICITIES OF TWO NEURAMINIDASES FROM TRICHOMONAS FETUSCRAMPEN M; VON NICOLAI H; ZILLIKEN F et al.1979; Z. (HOPPE-SEYLER'S) PHYSIOL. CHEM.; DEU; DA. 1979; VOL. 360; NO 12; PP. 1703-1712; ABS. GER; BIBL. 25 REF.Article
NEURAMINIDASE AUS CORYNEBACTERIUM HAEMOLYTICUMVON NICOLAI H; MULLER HE; ZILLIKEN F et al.1975; Z. (HOPPE-SEYLER'S) PHYSIOL. CHEM.; DTSCH.; DA. 1975; VOL. 356; NO 1; PP. 105-107; ABS. ANGL.; BIBL. 10REF.Conference Paper
A newly discovered sialidase from Gardnerella vaginalisVON NICOLAI, H; HAMMANN, R; SALEHNIA, S et al.Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology. 1984, Vol 258, Num 1, pp 20-26, issn 0176-6724Article
New isoflavonoids as inhibitors of porcine 5-lipoxygenaseVOSS, C; SEPULVEDA-BOZA, S; ZILLIKEN, F. W et al.Biochemical pharmacology. 1992, Vol 44, Num 1, pp 157-162, issn 0006-2952Article
ALTERATION OF PLASMA LIPIDS AND INTERMEDIATES OF LIPID METABOLISM IN HEALTHY FASTING VOLUNTEERS BY ETHANOL AND FRUCTOSESCHNEIDER J; TESDORPF M; KAFFARNIK H et al.1976; RES. EXPER. MED.; GERM.; DA. 1976; VOL. 167; NO 2; PP. 159-170; BIBL. 1 P.Article
Inhibition of in vitro microsomal lipid peroxidation by isoflavonoidsHEM CHANDRA JHA; VON RECKLINGHAUSEN, G; ZILLIKEN, F et al.Biochemical pharmacology. 1985, Vol 34, Num 9, pp 1367-1369, issn 0006-2952Article
Inhibitors of hydrogen peroxide-induced haemolysis of bovine erythrocytesHEM CHANDRA JHA; BERGMANN, C; ZILLIKEN, F et al.Biochemical pharmacology. 1984, Vol 33, Num 12, pp 1893-1895, issn 0006-2952Article
KONDENSIERTE FURANE. XLVII: SYNTHESE VON 1H-PYRANO (3,4-B) BENZOFURAN-1-ON UND DERIVATEN = FURANNES CONDENSES. XLVII: SYNTHESE DE 1H-PYRANNO (3,4-B) BENZOFURANNONE-1 ET DE DERIVESCHATTERJEA JN; SAHAI RP; SWAROOPA BB et al.1980; CHEM. BER.; ISSN 0009-2940; DEU; DA. 1980; VOL. 113; NO 11; PP. 3656-3661; ABS. ENG; BIBL. 14 REF.Article
6,7,4'-Trihydroxyisoflavan: a potent and selective inhibitor of 5-lipoxygenase in human and porcine peripheral blood leukocytesKUHL, P; SHILOH, R; JHA, H et al.Prostaglandins. 1984, Vol 28, Num 6, pp 783-804, issn 0090-6980Article
Clinical studies with coenzyme Q10 in patients with congestive heart failureSCHNEEBERGER, W; ZILLIKEN, F; MORITZ, J et al.Drugs under experimental and clinical research. 1984, Vol 10, Num 7, pp 503-512, issn 0378-6501Article